Additionally, the single RBBP8 marker was able to distinguish bladder cancer patients from patients with neoplasms of another urological origin (malignant control set) with high specificity (90.8%, AUC 0.686, 95% CI 0.583–0.789). This evidence concerns the gene RBBP8 and urinary bladder carcinoma.